The FDA has accepted for Priority Review the BLA for tividenofusp alfa for the treatment of Hunter syndrome, also known as MPS II.

After The Times published an interview with John Green about his new book on tuberculosis, many readers wrote to share their ...

Colon cancer remains a major global health concern, ranking third among the most diagnosed cancers and the leading cause of ...